MX2012004448A - Clones infecciosos de torque teno virus. - Google Patents

Clones infecciosos de torque teno virus.

Info

Publication number
MX2012004448A
MX2012004448A MX2012004448A MX2012004448A MX2012004448A MX 2012004448 A MX2012004448 A MX 2012004448A MX 2012004448 A MX2012004448 A MX 2012004448A MX 2012004448 A MX2012004448 A MX 2012004448A MX 2012004448 A MX2012004448 A MX 2012004448A
Authority
MX
Mexico
Prior art keywords
vaccines
ttv
virus
infectious clones
torque teno
Prior art date
Application number
MX2012004448A
Other languages
English (en)
Inventor
Jay Gregory Calvert
James Richard Thompson
Gregory Paul Nitzel
Robert Gerard Ankenbauer
Donna Steuerwald Dunyak
Jacqueline Gayle Marx
Nancee Lois Oien
Douglas Steven Pearce
Mira Ivanova Stoeva
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/005662 external-priority patent/WO2010044889A2/en
Application filed by Pfizer filed Critical Pfizer
Publication of MX2012004448A publication Critical patent/MX2012004448A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Abstract

La presente invención está dirigida a secuencias de nucleótido y aminoácido novedosas de Torque teno virus ("TTV'), que incluyen genotipos novedosos de las mismas, todos los cuales son útiles en la preparación de vacunas para el tratamiento y prevención de enfermedades en cerdos y otros animales. Las vacunas proporcionadas de acuerdo con la práctica de la invención son efectivas contra múltiples genotipos y aislados de TTV de cerdo. Los anticuerpos policlonales y monoclonales de diagnóstico y terapéuticos también son una característica de la presente invención, ya que son clones infecciosos útiles en la propagación del virus y en la preparación de las vacunas. Los aspectos particularmente importantes de la invención incluyen vacunas que proporcionan proteína TTV ORF1, o fragmentos de péptido de la misma, como antígeno.
MX2012004448A 2009-10-16 2010-04-16 Clones infecciosos de torque teno virus. MX2012004448A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2009/005662 WO2010044889A2 (en) 2008-10-16 2009-10-16 Torque teno virus (ttv) isolates and compositions
PCT/US2010/031373 WO2011046634A1 (en) 2009-10-16 2010-04-16 Infectious clones of torque teno virus

Publications (1)

Publication Number Publication Date
MX2012004448A true MX2012004448A (es) 2012-05-08

Family

ID=43876969

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012004448A MX2012004448A (es) 2009-10-16 2010-04-16 Clones infecciosos de torque teno virus.

Country Status (7)

Country Link
EP (1) EP2488185A4 (es)
JP (1) JP2013507918A (es)
CN (2) CN102655871A (es)
AU (1) AU2010307250B2 (es)
CA (1) CA2775277A1 (es)
MX (1) MX2012004448A (es)
WO (1) WO2011046634A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140286980A1 (en) * 2011-06-08 2014-09-25 Zoetis Llc Infectious clones of torque teno virus
CN102998453B (zh) * 2012-11-23 2014-10-08 广东海大畜牧兽医研究院有限公司 一种猪Ⅰ型细环病毒TTSuV1抗体间接ELISA诊断试剂盒及其制备方法
CN106867972A (zh) * 2015-12-11 2017-06-20 上海交通大学医学院附属第九人民医院 小细环病毒及其获得方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
SE9901601D0 (sv) * 1999-05-04 1999-05-04 Tripep Ab Peptides from the TT virus sequence and monospecific antibodies binding to the TT virus
CN1749397B (zh) * 2004-08-18 2010-12-08 金宁一 共表达猪圆环病毒及口蹄疫病毒的二联重组活载体疫苗
CA2739469A1 (en) * 2008-10-16 2010-04-22 Pfizer Inc. Torque teno virus (ttv) isolates and compositions

Also Published As

Publication number Publication date
CN102655871A (zh) 2012-09-05
AU2010307250B2 (en) 2013-09-26
CA2775277A1 (en) 2011-04-21
JP2013507918A (ja) 2013-03-07
WO2011046634A1 (en) 2011-04-21
CN103865955A (zh) 2014-06-18
EP2488185A4 (en) 2013-06-05
AU2010307250A1 (en) 2012-04-12
EP2488185A1 (en) 2012-08-22

Similar Documents

Publication Publication Date Title
WO2010044889A3 (en) Torque teno virus (ttv) isolates and compositions
PH12016500859A1 (en) Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
IN2012DN01328A (es)
GEP20217260B (en) Antibody neutralizing human respiratory syncytial virus
NZ600768A (en) Human antibodies to human angiopoietin-like protein 4
EP3266464A3 (en) Yeast-based therapeutic for chronic hepatitis b infection
MX2011012039A (es) Anticuerpos bloqueadores anti-dkk-1 y sus usos.
EA201000207A1 (ru) Новые иммуногенные эпитопы для иммунотерапии
MX340014B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2012008998A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2012009000A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
RU2008150400A (ru) Новая детерминанта вирулентности в пределах структурного гликопротеина е2 вируса классической лихорадки свиней
EA201170353A1 (ru) Антитела против гепатита с и их применение
NZ594480A (en) Methods and compositions for diagnosis and treatment of cancer
NO20090178L (no) Vaksiner for malaria
PH12019500592A1 (en) New swine influenza vaccine
WO2008124646A3 (en) Use of amyloid proteins as vaccine scaffolds
WO2009152147A3 (en) Compositions and methods for dengue virus (dv) treatment and vaccination
EA201491851A1 (ru) Композиции и способы для лечения болезни альцгеймера
MX341536B (es) Epitopo y anticuerpos beta amiloide de oligomero especifico.
RU2013102073A (ru) Антитела, подходящие для пассивной иммунизации против гриппа
NZ602693A (en) Immunogenic proteins and compositions for the treatment and prevention of streptococcus agalactiae
GEP201706766B (en) Methods and compositions for vaccinating against staphylococcus aureus
EP2528931A4 (en) CYCLOVIRUS AND USE METHOD THEREFOR
WO2006137938A3 (en) Antibody fragments for protection from pathogen infection and methods of use thereof

Legal Events

Date Code Title Description
GB Transfer or assignment

Owner name: ZOETIS LLC

HC Change of company name or juridical status

Owner name: ZOETIS LLC

FA Abandonment or withdrawal